Form 4 for RMD ResMed|
Accepted 2025-12-02 00:00:00 ET · period of report 2025-12-01 · accession 0000943819-25-000184 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | 2025-12-01 | RMD | Sandercock Brett | CFO | S - Sale | $244.16 | -1,000 | 87.5K | -1% | -$244.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2025-12-01 | S | D | 1,000 | $244.16 | 87,495 | D | — | — |